Try our beta test site
170 studies found for:    GVHD [CONDITION] | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Pilot Study of Telmisartan (Micardis) For the Prevention of Acute Graft vs. Host Disease Post Allogeneic Hematopoietic Stem Cell Transplantation
Condition: GVHD
Intervention: Drug: Telmisartan
2 Recruiting Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Condition: Graft vs Host Disease
Intervention: Drug: Pregnyl®
3 Recruiting Maraviroc as GVHD Prophylaxis in Transplant Recipients
Conditions: Diagnoses That Require Stem Cell Transplant;   Graft Versus Host Disease (GVHD)
Intervention: Drug: Maraviroc
4 Recruiting Early Detection of Mucosal Abnormalities in Graft-versus-host Disease
Condition: Graft Versus Host Disease
Intervention: Device: Probe based confocal laser endomicroscopy (Cellvizio)
5 Recruiting Multi Donor Mismatched Stem Cell Transplantation (MDT)
Condition: Graft-Versus-Host Disease
Intervention: Procedure: Multi donor stem cell transplantation
6 Not yet recruiting A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Conditions: Graft Vs Host Disease;   GVHD
Interventions: Drug: Pacritinib;   Drug: Sirolimus;   Drug: Tacrolimus
7 Recruiting Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
Conditions: Graft Versus Host Disease;   GVHD
Interventions: Drug: Panobinostat;   Drug: Sirolimus;   Drug: Tacrolimus
8 Recruiting Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Condition: Grades B-D Acute Graft Versus Host Disease
Intervention:
9 Recruiting Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft Versus Host Disease;   Chronic GVHD;   Complications of Organ Transplant Stem Cells
Interventions: Other: Treg-enriched infusion;   Drug: Interleukin-2
10 Recruiting Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
Condition: Graft Versus Host Disease (GVHD)
Interventions: Procedure: extracorporeal photopheresis;   Other: laboratory biomarker analysis
11 Recruiting BMT Auto MSCs GvHD Ph 1
Conditions: Graft Versus Host Disease;   Acute Graft Versus Host Disease;   Chronic Graft Versus Host Disease
Intervention: Biological: Autologous mesenchymal stromal cells (MSCs)
12 Not yet recruiting A Study of Obinutuzumab for Prevention of Chronic Graft-vs.-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
Condition: Graft vs. Host Disease
Interventions: Drug: Obinutuzumab;   Drug: Placebo
13 Recruiting Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Interventions: Drug: Natalizumab;   Drug: Methylprednisolone
14 Recruiting A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)
Condition: Acute GVHD
Interventions: Drug: Sirolimus;   Drug: Prednisone
15 Not yet recruiting Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD
Condition: Graft-versus-host Disease
Interventions: Biological: PRP eye drops;   Biological: PPP eye drops
16 Recruiting A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host-disease
Interventions: Procedure: Extracorporeal Photopheresis (ECP);   Drug: Interleukin-2
17 Recruiting Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
Condition: Graft Vs Host Disease
Intervention: Dietary Supplement: Calcipotriene
18 Recruiting Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche
Condition: Graft-vs-Host Disease
Intervention:
19 Recruiting A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Abatacept
20 Recruiting Multiple Donor Treg DLI for Severe Refractory Chronic GVHD
Condition: Chronic Graft Versus Host Disease
Intervention: Biological: T reg DLI

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.